Form 20FR12G/A - Registration of securities [Section 12(g)]: [Amend]
SEC Accession No. 0001144204-05-026745
Filing Date
2005-08-23
Accepted
2005-08-23 15:07:42
Documents
14

Document Format Files

Seq Description Document Type Size
1 v024504_20fr12ga.htm 20FR12G/A 2688371
2 v024504_ex4-5.htm EX-4.5 110925
3 v024504_ex4-8.htm EX-4.8 670930
4 GRAPHIC form1x18x1.jpg GRAPHIC 3714
5 GRAPHIC form2x19x1.jpg GRAPHIC 13528
6 GRAPHIC form3x39x1.jpg GRAPHIC 25350
7 v024504_ex4-9.htm EX-4.9 148160
8 v024504_ex4-10.htm EX-4.10 215192
9 v024504_ex4-25.htm EX-4.25 192015
10 v024504_ex4-26.htm EX-4.26 368588
11 v024504_ex4-27.htm EX-4.27 47657
12 v024504_ex15-1.htm EX-15.1 4283
13 v024504_ex15-2.htm EX-15.2 5813
14 filename14.htm CORRESP 31674
  Complete submission text file 0001144204-05-026745.txt   4544067
Mailing Address KIRYAT WEIZMANN BUILDING 3 REHOVOT76100 ISRAEL L3 00000
Business Address KIRYAT WEIZMANN BUILDING 3 REHOVOT76100 ISRAEL L3
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

EIN.: 000000000
Type: 20FR12G/A | Act: 34 | File No.: 000-51310 | Film No.: 051043557
SIC: 2834 Pharmaceutical Preparations